This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow stromal cells
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Epidermal melanocyte (HEMa-LP)
Immature bone marrow-derived dendritic cell
Leukemia cell (K562)
Lung cancer cell (NCI_H69)
Lung cancer cell (SBC-3)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Mature bone marrow-derived dendritic cell
Metastatic gastric cacncer cell (AZP7a)
Metastatic gastric cancer cell (AZ521)
Multiple myeloma cells (KMS-11)
Multiple myeloma cells (RPMI8226)
Multiple myeloma cells (U266)
Plasma
By sample status
24 hr culture
72 hr culture
Hypoxic condition (24 hr)
Multiple myeloma patients
Normal
Normal_old
Survived under long-term hypoxia
Transplant islets into mouse xenotransplantation-rejected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-504-5p
MIMAT0002875
0.0e+0
2.9e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
4.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
3.0e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
2.2e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
1.9e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
4.6e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
5.0e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
4.4e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000437_1
25
/
0
/
25
mmu-miR-504-5p
MIMAT0004889
0.0e+0
4.1e-1
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Blood. 2012 Jan 19;119(3):756-66. doi: 10.1182/blood-2011-02-338004. Epub 2011 Oct 26.
MIPF0000437_1
25
/
0
/
25
mmu-miR-504-5p
MIMAT0004889
0.0e+0
2.5e-1
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Blood. 2012 Jan 19;119(3):756-66. doi: 10.1182/blood-2011-02-338004. Epub 2011 Oct 26.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
3.7e-1
Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
5.5e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
3.8e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
9.3e-4
9.3e-4
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
1.1e-3
1.1e-3
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
6.6e-9
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000437_1
25
/
0
/
25
rno-miR-504
MIMAT0012830
0.0e+0
4.4e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000437_1
25
/
0
/
25
rno-miR-504
MIMAT0012830
0.0e+0
2.4e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000437_1
25
/
0
/
25
mmu-miR-504-5p
MIMAT0004889
0.0e+0
1.7e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
0.0e+0
3.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000437_1
25
/
0
/
25
rno-miR-504
MIMAT0012830
0.0e+0
4.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000437_1
25
/
0
/
25
rno-miR-504
MIMAT0012830
0.0e+0
3.6e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000437_1
25
/
0
/
25
rno-miR-504
MIMAT0012830
0.0e+0
4.0e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000437_1
25
/
0
/
25
rno-miR-504
MIMAT0012830
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000437_1
25
/
0
/
25
mmu-miR-504-5p
MIMAT0004889
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000437_1
25
/
0
/
25
hsa-miR-504-5p
MIMAT0002875
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000437_1
25
/
0
/
25
[1]